Literature DB >> 23860754

Substratum compliance modulates corneal fibroblast to myofibroblast transformation.

Britta Dreier1, Sara M Thomasy, Rima Mendonsa, Vijay Krishna Raghunathan, Paul Russell, Christopher J Murphy.   

Abstract

PURPOSE: The transformation of fibroblasts to myofibroblasts is critical to corneal wound healing, stromal haze formation, and scarring. It has recently been demonstrated that the provision of biomimetic substratum topographic cues inhibits the progression toward the myofibroblast phenotype under the influence of transforming growth factor β1 (TGF-β1). The objective of this study was to determine the effect of another fundamental biophysical cue, substrate compliance, on TGF-β1-induced myofibroblast transformation of primary corneal cells isolated from human and rabbit corneas.
METHODS: Human and rabbit corneal fibroblasts were cultured on surfaces of varying substrate compliance (4-71 kPa) and tissue culture plastic (TCP) (> 1 gigapascal [GPa]). Cells were cultured in media containing TGF-β1 at concentrations of 0, 1, or 10 ng/mL for 72 hours. RNA and protein were collected from cells cultured on polyacrylamide gels and TCP and were analyzed for the expression of α-smooth muscle actin (α-SMA), a key marker of myofibroblast transformation, using quantitative PCR, immunocytochemistry, and Western blot.
RESULTS: Cells grown on more compliant substrates demonstrated significantly reduced amounts of α-SMA mRNA compared with TCP. Immunocytochemistry and Western blot analysis determining the presence of α-SMA corroborated this finding, thus confirming a reduced transformation to the myofibroblast phenotype on more compliant substrates compared with cells on TCP in the presence of TGF-β1.
CONCLUSIONS: These data indicate that substrate compliance modulates TGF-β1-induced expression of α-SMA and thus influences myofibroblast transformation in the corneal stroma. This provides further evidence that biomimetic biophysical cues inhibit myofibroblast transformation and participate in stabilizing the native cellular phenotype.

Entities:  

Keywords:  biophysical cues; corneal wound healing; myofibroblast transformation; α-smooth muscle actin

Mesh:

Substances:

Year:  2013        PMID: 23860754      PMCID: PMC3757908          DOI: 10.1167/iovs.12-11575

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  37 in total

Review 1.  Wound healing in the cornea: a review of refractive surgery complications and new prospects for therapy.

Authors:  Marcelo V Netto; Rajiv R Mohan; Renato Ambrósio; Audrey E K Hutcheon; James D Zieske; Steven E Wilson
Journal:  Cornea       Date:  2005-07       Impact factor: 2.651

2.  Nanoscale topography-induced modulation of fundamental cell behaviors of rabbit corneal keratocytes, fibroblasts, and myofibroblasts.

Authors:  Simon A Pot; Sara J Liliensiek; Kathern E Myrna; Ellison Bentley; James V Jester; Paul F Nealey; Christopher J Murphy
Journal:  Invest Ophthalmol Vis Sci       Date:  2009-10-29       Impact factor: 4.799

3.  The scale of substratum topographic features modulates proliferation of corneal epithelial cells and corneal fibroblasts.

Authors:  S J Liliensiek; S Campbell; P F Nealey; C J Murphy
Journal:  J Biomed Mater Res A       Date:  2006-10       Impact factor: 4.396

4.  Nano- and microscale holes modulate cell-substrate adhesion, cytoskeletal organization, and -beta1 integrin localization in SV40 human corneal epithelial cells.

Authors:  Nancy W Karuri; Teresa J Porri; Ralph M Albrecht; Christopher J Murphy; Paul F Nealey
Journal:  IEEE Trans Nanobioscience       Date:  2006-12       Impact factor: 2.935

5.  Modulation of human vascular endothelial cell behaviors by nanotopographic cues.

Authors:  Sara J Liliensiek; Joshua A Wood; Jiang Yong; Robert Auerbach; Paul F Nealey; Christopher J Murphy
Journal:  Biomaterials       Date:  2010-04-18       Impact factor: 12.479

6.  Corneal keratocytes: phenotypic and species differences in abundant protein expression and in vitro light-scattering.

Authors:  James V Jester; Abhijit Budge; Steven Fisher; Jiying Huang
Journal:  Invest Ophthalmol Vis Sci       Date:  2005-07       Impact factor: 4.799

7.  Tissue stiffness, latent TGF-beta1 activation, and mechanical signal transduction: implications for the pathogenesis and treatment of fibrosis.

Authors:  Boris Hinz
Journal:  Curr Rheumatol Rep       Date:  2009-04       Impact factor: 4.592

Review 8.  Meet the corneal myofibroblast: the role of myofibroblast transformation in corneal wound healing and pathology.

Authors:  Kathern E Myrna; Simon A Pot; Christopher J Murphy
Journal:  Vet Ophthalmol       Date:  2009 Nov-Dec       Impact factor: 1.644

9.  Determining the mechanical properties of human corneal basement membranes with atomic force microscopy.

Authors:  Julie A Last; Sara J Liliensiek; Paul F Nealey; Christopher J Murphy
Journal:  J Struct Biol       Date:  2009-03-31       Impact factor: 2.867

Review 10.  Fibrotic disorders in the eye: targets of gene therapy.

Authors:  Shizuya Saika; Osamu Yamanaka; Takayoshi Sumioka; Takeshi Miyamoto; Ken-ichi Miyazaki; Yuka Okada; Ai Kitano; Kumi Shirai; Sai-ichi Tanaka; Kazuo Ikeda
Journal:  Prog Retin Eye Res       Date:  2008-02-01       Impact factor: 21.198

View more
  22 in total

Review 1.  Biomechanical relationships between the corneal endothelium and Descemet's membrane.

Authors:  Maryam Ali; VijayKrishna Raghunathan; Jennifer Y Li; Christopher J Murphy; Sara M Thomasy
Journal:  Exp Eye Res       Date:  2016-09-14       Impact factor: 3.467

2.  YAP and TAZ are distinct effectors of corneal myofibroblast transformation.

Authors:  Santoshi Muppala; Vijay Krishna Raghunathan; Iman Jalilian; Sara Thomasy; Christopher J Murphy
Journal:  Exp Eye Res       Date:  2018-12-19       Impact factor: 3.467

Review 3.  Mechanical interactions and crosstalk between corneal keratocytes and the extracellular matrix.

Authors:  W Matthew Petroll; Miguel Miron-Mendoza
Journal:  Exp Eye Res       Date:  2015-04       Impact factor: 3.467

4.  Modulation of human corneal stromal cell differentiation by hepatocyte growth factor and substratum compliance.

Authors:  Hidetaka Miyagi; Iman Jalilian; Christopher J Murphy; Sara M Thomasy
Journal:  Exp Eye Res       Date:  2018-09-05       Impact factor: 3.467

5.  Latrunculin B and substratum stiffness regulate corneal fibroblast to myofibroblast transformation.

Authors:  Sara M Thomasy; Vijay Krishna Raghunathan; Hidetaka Miyagi; Alexander T Evashenk; Jasmyne C Sermeno; Geneva K Tripp; Joshua T Morgan; Christopher J Murphy
Journal:  Exp Eye Res       Date:  2018-02-06       Impact factor: 3.467

Review 6.  Wounding the cornea to learn how it heals.

Authors:  Mary Ann Stepp; James D Zieske; Vickery Trinkaus-Randall; Briana M Kyne; Sonali Pal-Ghosh; Gauri Tadvalkar; Ahdeah Pajoohesh-Ganji
Journal:  Exp Eye Res       Date:  2014-03-04       Impact factor: 3.467

7.  Gelam honey promotes ex vivo corneal fibroblasts wound healing.

Authors:  Alia Md Yusof; Norzana Abd Ghafar; Taty Anna Kamarudin; Kien-Hui Chua; Muhammad Fairuz Azmi; Sook-Luan Ng; Yasmin Anum Mohd Yusof
Journal:  Cytotechnology       Date:  2019-10-12       Impact factor: 2.058

8.  Tissue and cellular biomechanics during corneal wound injury and repair.

Authors:  Vijay Krishna Raghunathan; Sara M Thomasy; Peter Strøm; Bernardo Yañez-Soto; Shaun P Garland; Jasmyne Sermeno; Christopher M Reilly; Christopher J Murphy
Journal:  Acta Biomater       Date:  2017-05-27       Impact factor: 8.947

9.  Gene expression signatures in tree shrew sclera in response to three myopiagenic conditions.

Authors:  Lin Guo; Michael R Frost; Li He; John T Siegwart; Thomas T Norton
Journal:  Invest Ophthalmol Vis Sci       Date:  2013-10-21       Impact factor: 4.799

10.  ECM Stiffness Controls the Activation and Contractility of Corneal Keratocytes in Response to TGF-β1.

Authors:  Daniel P Maruri; Miguel Miron-Mendoza; Pouriska B Kivanany; Joshua M Hack; David W Schmidtke; W Matthew Petroll; Victor D Varner
Journal:  Biophys J       Date:  2020-09-23       Impact factor: 4.033

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.